Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.

Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:


Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

CompanyDrug NameStatusIndication Group
Pfizer ZYVOX Approved in USAAnti-infectives for systemic use
Pfizer Zyrtec Approved in USADermatologicals
Pfizer Zyrtec Approved in USARespiratory system
Lilly Zyprexa Approved in USANervous system
Bausch & Lomb Zylet Approved in USASensory organs
Critical Therapeutics Zyflo accomplished Phase IIDermatologicals
Critical Therapeutics Zyflo Approved in USARespiratory system
OXiGENE Zybrestat accomplished Phase IISensory organs
OXiGENE Zybrestat in Phase IIAntineoplastic & immunomodulating agents
OXiGENE Zybrestat in Phase IAntineoplastic & immunomodulating agents
OXiGENE Zybrestat accomplished Phase IIAntineoplastic & immunomodulating agents
Biovail Zovirax Approved in USAAnti-infectives for systemic use
AstraZeneca ZOMIG Approved in USANervous system
Novartis Zometa in Phase IIIAntineoplastic & immunomodulating agents
Novartis Zometa Approved in USA and EU, submitted for approval in JapanAntineoplastic & immunomodulating agents
Novartis Zometa in Phase IIMusculoskeletal system
Ferring ZOMACTON accomplished Phase IIISystemic hormonal preparations
Biovail Zolpidem ODT Approved in USANervous system
Pfizer Zithromax Approved in USAAnti-infectives for systemic use
Barrier Therapeutics Zimycan discontinuedDermatologicals

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.